NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/10/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization109.29 mln
Float23.09 mln
Earnings Date08/17/2026
EPS
3.53
Solid
P / E
0.93
Anomalous
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-5.09
Highly reliable
Relative Strength
86
/ 100
Strongly outperforming
Debt / Equity
0.33
Low leverage
Business Description
Fortress Biotech is a Florida-based pharmaceutical company that develops and sells a wide range of medical treatments, with a particular focus on skin conditions such as acne, rosacea, and fungal infections. Beyond dermatology, the company is advancing treatments for serious illnesses including cancer, rare genetic disorders, and post-surgical pain. It also has a growing pipeline of early and pre-clinical therapies spanning areas such as gout, brain tumors, and gene therapy. Founded in 2006 and originally known as Coronado Biosciences, the company works across multiple stages of drug development, from early research through to commercial sales.